MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 146 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,253,351 | +60394.6% | 35,972 | -4.3% | 0.34% | -35.0% |
| Q2 2023 | $8,684 | -23.2% | 37,594 | -19.5% | 0.52% | -25.8% |
| Q1 2023 | $11,308 | -15.2% | 46,679 | +1.6% | 0.69% | -15.7% |
| Q4 2022 | $13,335 | -99.6% | 45,943 | -9.9% | 0.82% | +277.5% |
| Q3 2022 | $3,315,000 | -22.0% | 51,007 | -14.0% | 0.22% | -17.1% |
| Q2 2022 | $4,248,000 | -41.3% | 59,343 | -19.5% | 0.26% | -31.7% |
| Q1 2022 | $7,235,000 | +23.3% | 73,734 | +6.5% | 0.38% | +33.7% |
| Q4 2021 | $5,869,000 | -0.5% | 69,261 | -6.3% | 0.29% | -7.1% |
| Q3 2021 | $5,899,000 | -17.7% | 73,936 | +0.5% | 0.31% | -18.8% |
| Q2 2021 | $7,166,000 | -15.3% | 73,564 | +1.7% | 0.38% | -24.8% |
| Q1 2021 | $8,462,000 | – | 72,342 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
| University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
| Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
| TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
| Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
| Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
| Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
| Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
| MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
| Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |